Litcius/Paper detail

Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention

Yoshihiro Ono, Yosuke Inoue, Tomotaka Kato, Kiyoshi Matsueda, Atsushi Oba, Takafumi Sato, Hiromichi Ito, Akio Saiura, Yu Takahashi

2021Cancers20 citationsDOIOpen Access PDF

Abstract

To achieve curative resection for pancreatic cancer during pancreaticoduodenectomy (PD), extensive portal vein (PV) resection, including porto-mesenterico-splenic confluence (PMSC), may sometimes be necessary if the tumor is close to the portal venous system. Recently, this extended resection has been widely accepted in high-volume centers for pancreatic resection due to its favorable outcomes compared with non-operative treatment. However, in patients with long-term survival, sinistral portal hypertension (SPH) occurs as a late-onset postoperative complication. These patients present gastrointestinal varices due to congested venous flow from the spleen, which may cause critical variceal bleeding. Since the prognosis of patients with pancreatic cancer has improved, owing to the development of chemotherapy and surgical techniques, SPH is no longer a negligible matter in the field of pancreatic cancer surgery. This review clarifies the pathogenesis and frequency of SPH after PD through PMSC resection and discusses its prediction and prevention.

Topics & Concepts

PancreaticoduodenectomyMedicinePortal hypertensionPancreatic cancerComplicationSplenic veinSurgeryVaricesResectionCancerInternal medicineCirrhosisPancreatic and Hepatic Oncology ResearchHepatocellular Carcinoma Treatment and PrognosisPancreatitis Pathology and Treatment
Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention | Litcius